$50B market cap ÷ 10 = $5B turnover. This is easy to achieve giving just one more FDA approval out of the plethora expected, and is not even taking into account the further pipeline of products. And cancer therapeutics is the gamechanger which can achieve this shareprice as a standalone product!
Understanding Telix, page-725
-
- There are more pages in this discussion • 472 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.32 |
Change
0.100(0.52%) |
Mkt cap ! $6.465B | |||
| Open | High | Low | Value | Volume |
| $19.30 | $19.50 | $19.08 | $22.36M | 1.160M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3890 | $19.32 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.34 | 100 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| TLX (ASX) Chart |